489 related articles for article (PubMed ID: 18093720)
1. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
2. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
3. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
4. Pap test--with or without vaginal smear?
Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
[TBL] [Abstract][Full Text] [Related]
5. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
6. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
7. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
8. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
[TBL] [Abstract][Full Text] [Related]
9. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury.
Simcock B; Sykes P; Laney M
N Z Med J; 2001 Aug; 114(1138):378-80. PubMed ID: 11589435
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
11. Cervical screening history in patients with early stage carcinoma of the cervix.
Abed Z; O'Leary M; Hand K; Flannelly G; Lenehan P; Murphy J; Foley M
Ir Med J; 2006 May; 99(5):140-2. PubMed ID: 16892918
[TBL] [Abstract][Full Text] [Related]
12. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
[TBL] [Abstract][Full Text] [Related]
13. Pathways to diagnosis of cervical cancer: screening history, delay in follow up, and smear reading.
Priest P; Sadler L; Peters J; Crengle S; Bethwaite P; Medley G; Jackson R
BJOG; 2007 Apr; 114(4):398-407. PubMed ID: 17166215
[TBL] [Abstract][Full Text] [Related]
14. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
[TBL] [Abstract][Full Text] [Related]
15. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
16. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
17. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
[TBL] [Abstract][Full Text] [Related]
18. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
[TBL] [Abstract][Full Text] [Related]
19. Papanicolaou smear history of patients developing cervical cancer: an assessment of screening protocols.
Bearman DM; MacMillan JP; Creasman WT
Obstet Gynecol; 1987 Feb; 69(2):151-5. PubMed ID: 3808501
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with tumour stage at presentation in invasive cervical cancer.
Ndlovu N; Kambarami R
Cent Afr J Med; 2003; 49(9-10):107-11. PubMed ID: 15298465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
